Axovant Gene Therapies Q2 EPS $(0.61) Down From $(0.28) YoY

Axovant Gene Therapies (NASDAQ:AXGT) reported quarterly losses of $(0.61) per share. This is a 117.86 percent decrease over losses of $(0.28) per share from the same period last year.

Benzinga · 11/08/2019 13:09

Axovant Gene Therapies (NASDAQ:AXGT) reported quarterly losses of $(0.61) per share. This is a 117.86 percent decrease over losses of $(0.28) per share from the same period last year.